1-70151134-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The ENST00000370952.4(LRRC40):āc.1511T>Cā(p.Phe504Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00015 in 1,521,428 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00012 ( 1 hom., cov: 32)
Exomes š: 0.00015 ( 1 hom. )
Consequence
LRRC40
ENST00000370952.4 missense
ENST00000370952.4 missense
Scores
8
11
Clinical Significance
Conservation
PhyloP100: 4.63
Genes affected
LRRC40 (HGNC:26004): (leucine rich repeat containing 40) Predicted to enable protein serine/threonine phosphatase activity. Predicted to be involved in signal transduction. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
LRRC7 (HGNC:18531): (leucine rich repeat containing 7) Predicted to be involved in several processes, including establishment or maintenance of epithelial cell apical/basal polarity; positive regulation of neuron projection development; and receptor clustering. Located in several cellular components, including centrosome; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -1 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.30115652).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC40 | NM_017768.5 | c.1511T>C | p.Phe504Ser | missense_variant | 13/15 | ENST00000370952.4 | NP_060238.3 | |
LRRC40 | XM_011541763.2 | c.857T>C | p.Phe286Ser | missense_variant | 11/13 | XP_011540065.1 | ||
LRRC40 | XM_047424520.1 | c.857T>C | p.Phe286Ser | missense_variant | 11/13 | XP_047280476.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC40 | ENST00000370952.4 | c.1511T>C | p.Phe504Ser | missense_variant | 13/15 | 1 | NM_017768.5 | ENSP00000359990 | P1 | |
LRRC7 | ENST00000441830.1 | n.193-614A>G | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152158Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
19
AN:
152158
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000266 AC: 66AN: 248094Hom.: 1 AF XY: 0.000224 AC XY: 30AN XY: 134018
GnomAD3 exomes
AF:
AC:
66
AN:
248094
Hom.:
AF XY:
AC XY:
30
AN XY:
134018
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000153 AC: 209AN: 1369270Hom.: 1 Cov.: 23 AF XY: 0.000157 AC XY: 108AN XY: 686122
GnomAD4 exome
AF:
AC:
209
AN:
1369270
Hom.:
Cov.:
23
AF XY:
AC XY:
108
AN XY:
686122
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000125 AC: 19AN: 152158Hom.: 1 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74328
GnomAD4 genome
AF:
AC:
19
AN:
152158
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
20
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 31, 2022 | The c.1511T>C (p.F504S) alteration is located in exon 13 (coding exon 13) of the LRRC40 gene. This alteration results from a T to C substitution at nucleotide position 1511, causing the phenylalanine (F) at amino acid position 504 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at